All Stories

  1. Complement in malaria immunity and vaccines
  2. Novel particles for malaria vaccines
  3. Iron deficiency, malaria, and low birth weight.
  4. Understanding how the RTS,S malaria vaccine works
  5. Targets of complement-fixing antibodies in protective immunity against malaria
  6. Understanding transmission-blocking immunity compared to clinical immunity in malaria
  7. Challenges and strategies for developing efficacious and long-lasting malaria vaccines
  8. Acquisition of Antibodies Against Endothelial Protein C Receptor–Binding Domains of Plasmodium falciparum Erythrocyte Membrane Protein 1 in Children with Severe Malaria
  9. Multiple morbidities in pregnancy: Time for research, innovation, and action
  10. Iron deficiency in pregnancy and poor birth outcomes
  11. Mechanism of immunity to malaria - blocking sporozoite infection
  12. Overcoming antigenic diversity of malaria vaccine candidates for better protection
  13. Combating low birth weight due to malaria infection in pregnancy.
  14. Antibodies generated by a vaccine against malaria in pregnancy
  15. Immunity to severe malaria in children
  16. Functional Conservation of the AMA1 Host-Cell Invasion Ligand Between P. falciparum and P. vivax: A Novel Platform to Accelerate Vaccine and Drug Development
  17. Understanding how immunity to malaria develops in children
  18. Identifying new drugs against malaria
  19. Impact of declining malaria transmission on human immunity
  20. The potential benefit of scaling up malaria prevention to reduce low birth weight in Africa
  21. Evaluating Complement-Mediated Humoral Immunity to P. falciparum Blood Stages
  22. Differing rates of antibody acquisition in malaria: implications for immunity and surveillance
  23. Functional Antibodies and Protection against Blood-stage Malaria
  24. A malaria vaccine in children with HIV
  25. A novel approach to identifying patterns of human invasion-inhibitory antibodies guides the design of malaria vaccines incorporating polymorphic antigens
  26. Specific antibodies to the PfRH5 invasion complex and protection from malaria
  27. A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies
  28. Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria
  29. Immunity to malaria in an era of declining malaria transmission
  30. Human Antibodies Fix Complement to Inhibit Plasmodium falciparum Invasion of Erythrocytes and Are Associated with Protection against Malaria
  31. Acquisition of Antibodies against Plasmodium falciparum Merozoites and Malaria Immunity in Young Children and the Influence of Age, Force of Infection, and Magnitude of Response
  32. Research priorities for the development and implementation of serological tools for malaria surveillance
  33. Limited antigenic diversity of Plasmodium falciparumapical membrane antigen 1 supports the development of effective multi-allele vaccines
  34. Opsonic phagocytosis of Plasmodium falciparummerozoites: mechanism in human immunity and a correlate of protection against malaria
  35. Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates
  36. Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria
  37. Sequential Processing of Merozoite Surface Proteins during and after Erythrocyte Invasion by Plasmodium falciparum
  38. Implications of the licensure of a partially efficacious malaria vaccine on evaluating second-generation vaccines
  39. Defining the Antigenic Diversity of Plasmodium falciparum Apical Membrane Antigen 1 and the Requirements for a Multi-Allele Vaccine against Malaria
  40. Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays
  41. Recent insights into humoral and cellular immune responses against malaria
  42. Selective Accumulation of Mature Asexual Stages of Plasmodium falciparum-Infected Erythrocytes in the Placenta
  43. Pathogenesis of Plasmodium falciparum malaria: the roles of parasite adhesion and antigenic variation